Product category: Electromedical instruments and instruments for neurological diagnosis
The Infrascanner Model 2000 is light-weight and handheld, and provides a simple, positive or negative graphic report.
The Infrascanner unit includes a sensor and a cradle. The sensor includes an eye safe NIR diode laser and an optical detector. The light to and from the laser and detector are optically coupled to the patient’s head through two disposable light guides. The detector signal is digitized and analyzed by a single board computer (SBC) in the sensor. The SBC receives the data from the detector and automatically adjusts the settings to ensure good data quality. The data is further processed by the SBC and the results are displayed on the screen.
The Infrascanner Model 2000 Integrates processing, display and control functions within the sensor. Has been ruggedized for improved durability – especially in remote locations and on the battlefield. Is versatile and its availability is enhanced by the ability to use regular AA batteries in addition to a rechargeable battery pack. The sensor is turned on by placing a disposable shield on the sensor and turned off by removing the disposable shield. The sensor can be powered either by a rechargeable NiMH battery pack or by four disposable AA batteries. The cradle is used to charge the rechargeable battery pack, if it is used in the sensor, and to copy the data from the sensor into a personal computer.
InfraScan, Inc. is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma.
Intracranial hematomas are an important and, if diagnosed early, treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries, and 40% of them have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. The Office of Naval Research funded the company in May, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multi-center clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a denovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.